Benlysta 120 mg

Benlysta 120 mg is a powder for solution used for intravenous administration. It contains belimumab, a monoclonal antibody indicated for specific autoimmune conditions. This medication is manufactured by GlaxoSmithKline Inc. in Canada.

Benlysta 120 mg is primarily used in the treatment of certain autoimmune diseases. It works by targeting specific cells in the immune system to help reduce inflammation and disease activity. Patients often wonder, 'What is Benlysta used for?' This medication is typically prescribed for conditions where the immune system attacks healthy tissues.

Common effects of Benlysta 120 mg may include infusion reactions, such as fever, nausea, and headache. Some patients may also experience fatigue or muscle pain. These effects are generally mild and temporary, but severe reactions are possible and should be reported to a healthcare provider immediately.

Benlysta 120 mg should be administered under the supervision of a healthcare professional. It is important to inform your doctor about any allergies or existing medical conditions before starting treatment. Patients should also be monitored for signs of infection, as this medication can affect the immune system.

Benlysta 120 mg may interact with other medications, including those that suppress the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain over-the-counter drugs should also be used with caution.